{"name":"HighTide Biopharma Pty Ltd","slug":"hightide-biopharma-pty-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxOTWRKUFFxSkZqdnVqMGlXaEVwaWtLV0dJc21RU2tqeGZpSzhhbEplcWFNUG8zVlk4OE9UVW56VmY0NmJkYjJTTTE0M3oxNlhteE1pNk1IQXhzZzVmTTZYNkVFR2tXMmlDdl84c1c5RHBSQU4wTDFhNzlCVDY5SldIcTBreHg0NnlRR0E0Q0hNM2xMRU43bXMwS0lkbGRKSzhHY2pWVkw2T29zd2w5TEItSW1uQjE5ejVOcmdZNWRQOTZfeFZyUEZucG9jZlZUMk9DMkhacVVPVngyU19ia04tUV9KZTZjM2duUldRN1Yzb2NraTB3VW5mbm9odEpJSEZxS2NvOWlZLThzaTRaWF9uZE9IRmVXd0d2YXVmRUhIOEtIaVItOVJzSGF6M0hDY3dENVhDODQzMzZ6U1BkWWlOdDM5Q2U?oc=5","date":"2026-04-08","type":"pipeline","source":"Barchart.com","summary":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma AstraZeneca, Eccogene, Pfizer, Sciwind Biosciences USA Co., Ltd., MediciNova - Barcha","headline":"Diabetes Market: Rapid Increment Driven by Innovation by 2032 – DelveInsight | Eli Lilly and Company, Regor Pharma Astra","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-30","type":"earnings","source":"simplywall.st","summary":"High Tide (TSXV:HITI) Q4 Loss Of CA$45.6 Million Tests Bullish Growth Narratives - simplywall.st","headline":"High Tide (TSXV:HITI) Q4 Loss Of CA$45.6 Million Tests Bullish Growth Narratives","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2026-01-24","type":"pipeline","source":"simplywall.st","summary":"The Bull Case For High Tide (TSXV:HITI) Could Change Following New Voting Agreements Learn Why - simplywall.st","headline":"The Bull Case For High Tide (TSXV:HITI) Could Change Following New Voting Agreements Learn Why","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-10-23","type":"pipeline","source":"simplywall.st","summary":"Here's Why High Tide (CVE:HITI) Can Manage Its Debt Responsibly - simplywall.st","headline":"Here's Why High Tide (CVE:HITI) Can Manage Its Debt Responsibly","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixAJBVV95cUxPVEdFQnVwd0NPdlBlZlVUa2p5M0RuRnJlN1l1dHhNMFdicmZoRTZtTWVNeHRZeHJmZnRyanNHT2hQYy1TQWFZT2wzVXdncjF0NWMyNGNYN3hzeVozTGx3aWh4eW9nVGc4RVI0R2o3bE5nVWR3NGlaejNNTkl2dzl3NVRnQ3J1YWFYVXpZYzFrMGgtakdLTUgtUUo5UFNPdE14ZjJwby16VTJoVXlHRDFFVnJuaGJLWUlvOGszbTdFOTZGemhkUjIyaG44bTk2bE5hV001YU9Sa096RWFxRENybTlSX0dVc3VBanVONTl6Y2VqVTMxQ3M0eXByQUxmak5NRV9JZXF5aWkxNlhaYW9tRC01Y0JZcktubGRSdEJlSDEwOUxOQ3RtWkJhOVI0YTM0ZFJxNEx1UHMxV0p4VGRfNGlfNnE?oc=5","date":"2025-09-23","type":"pipeline","source":"PR Newswire","summary":"SGLT2 Inhibitors Market to Expand by 2034 as Companies Leverage Emerging Opportunities in Indications Such as Heart Failure, MASH, Obesity, PCOS, and Others | DelveInsight - PR Newswire","headline":"SGLT2 Inhibitors Market to Expand by 2034 as Companies Leverage Emerging Opportunities in Indications Such as Heart Fail","sentiment":"neutral"},{"url":"https://news.google.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?oc=5","date":"2025-08-20","type":"pipeline","source":"simplywall.st","summary":"Even With A 26% Surge, Cautious Investors Are Not Rewarding High Tide Inc.'s (CVE:HITI) Performance Completely - simplywall.st","headline":"Even With A 26% Surge, Cautious Investors Are Not Rewarding High Tide Inc.'s (CVE:HITI) Performance Completely","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6wFBVV95cUxPOXduWVp5b19OWFd5R1BzMkZvcldONC0xVEc3NTh1aEhJLU5HV1Q0Ni0zZlVxUGFzemZoRzBWdmVPOUJ0eXVnZVdKeGtQVTlQMmJNdEwzaWptc2puZTg2dFM5Vkk1XzlUX3R6bjllTTRVeGhzcGlzVTdkNXk0amx3bS1HWUY1UHdWOFlCNnhqS2ZlLVVhRmdHQWhDV3VncVRDcUlpUnU5b204Q3BEazN3bXRBclJZdDByMjQxNDZCX3RIWG9UVWc3YlV6Uk9UWGUyeGUyUmhlbEV0ZjVfYlJmbGVYMDR5YXBFeXAw?oc=5","date":"2023-07-12","type":"pipeline","source":"PR Newswire","summary":"Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight - PR Newswire","headline":"Liver Cirrhosis Market to Observe Impressive Growth at a CAGR of 6.3% by 2032, Predicts DelveInsight","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}